|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
5 July 2021 |
|
Main ID: |
NCT02749201 |
|
Date of registration:
|
20/04/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Transmitted Light Tissue Thickness Analysis (TiLTT)
TiLLT |
|
Scientific title:
|
Transmitted Light Tissue Thickness Analysis (TiLTT) |
|
Date of first enrolment:
|
April 2016 |
|
Target sample size:
|
10 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02749201 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Danny Sherwinter, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Maimonides Medical Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Subject has provided informed consent
- Subject is between the ages of 18 and 80 years of age
- Subject is scheduled for and undergoes primary sleeve gastrectomy
Exclusion Criteria:
- Revisional Bariatric Surgery
Age minimum:
18 Years
Age maximum:
85 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Morbid Obesity
|
|
Intervention(s)
|
|
Device: Gastrisail
|
|
Primary Outcome(s)
|
|
Number of Patients With Transmitted Light Intensity to Gastric Wall Thickness)
[Time Frame: intraoperative]
|
|
Secondary ID(s)
|
|
2015-06-15-MMC
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|